View Post

Gene-targeted drug slowed growth of prostate cancer

In In The News by Barbara Jacoby

By: Stephen Feller From: Tumors shrank in one-third of participants in a study, all of whom had untreatable cancer. A precision drug, designed to treat tumors with specific genetic mutations and used to treat women with inherited cancers, was shown to benefit men with untreatable prostate cancer, according to a recent clinical trial. Olaparib affected cancer in one-third of …